Related Experiment Video
Updated: Jun 20, 2026

07:42
On-Chip Crystallization and Large-Scale Serial Diffraction at Room Temperature
Published on: March 11, 2022
CCR3: Shedding new light on a dark problem?
1Yale University School of Medicine, New Haven, CT 06510, USA. alan.mason@yale.edu
Journal of Molecular Cell Biology
|August 18, 2009
Abstract:
A recent work by Ambati et al. represents a bold step towards a more effective diagnosis and treatment of age-related macular degeneration, with the new evidence showing that CCR3, a chemokine receptor, is an early marker of and potential therapeutic target for choroidal neovascularization development. In the wake of such a novel and significant finding, additional illumination to confirm and consolidate the promise shown by CCR3 will soon follow.
